{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:33:20Z","timestamp":1793694800238,"version":"4.5.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs, Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C24E\/22\/035"],"award-info":[{"award-number":["C24E\/22\/035"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["181545"],"award-info":[{"award-number":["181545"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09844-z","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:40:18Z","timestamp":1773384018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preferential remdesivir triphosphate incorporation by SARS-CoV-2 polymerase is altered to ATP by the S759A mutation"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8259-6201","authenticated-orcid":false,"given":"Calvin J.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizar F.","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3981-0284","authenticated-orcid":false,"given":"Hery W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2168-1103","authenticated-orcid":false,"given":"Quinten","family":"Goovaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7551-8897","authenticated-orcid":false,"given":"Brent","family":"De Wijngaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-5806","authenticated-orcid":false,"given":"Matthias","family":"G\u00f6tte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8897-324X","authenticated-orcid":false,"given":"Kalyan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"9844_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","volume":"154","author":"KL Seley-Radtke","year":"2018","unstructured":"Seley-Radtke, K. L. & Yates, M. K. The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: early structural modifications to the nucleoside scaffold. Antivir. Res. 154, 66\u201386 (2018).","journal-title":"Antivir. Res."},{"key":"9844_CR2","doi-asserted-by":"publisher","unstructured":"Singh, A. K. & Das, K. Insights into HIV-1 Reverse transcriptase (RT) inhibition and drug resistance from thirty years of structural studies. Viruses 14, https:\/\/doi.org\/10.3390\/v14051027 (2022).","DOI":"10.3390\/v14051027"},{"key":"9844_CR3","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s40265-014-0247-z","volume":"74","author":"GM Keating","year":"2014","unstructured":"Keating, G. M. Sofosbuvir: a review of its use in patients with chronic hepatitis C. Drugs 74, 1127\u20131146 (2014).","journal-title":"Drugs"},{"key":"9844_CR4","doi-asserted-by":"publisher","first-page":"11979","DOI":"10.1074\/jbc.M210914200","volume":"278","author":"SS Carroll","year":"2003","unstructured":"Carroll, S. S. et al. Inhibition of hepatitis C virus RNA replication by 2\u2019-modified nucleoside analogs. J. Biol. Chem. 278, 11979\u201311984 (2003).","journal-title":"J. Biol. Chem."},{"key":"9844_CR5","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","volume":"295","author":"CJ Gordon","year":"2020","unstructured":"Gordon, C. J. et al. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J. Biol. Chem. 295, 6785\u20136797 (2020).","journal-title":"J. Biol. Chem."},{"key":"9844_CR6","doi-asserted-by":"publisher","first-page":"101849","DOI":"10.1016\/j.isci.2020.101849","volume":"23","author":"TL Dangerfield","year":"2020","unstructured":"Dangerfield, T. L., Huang, N. Z. & Johnson, K. A. Remdesivir is effective in combating COVID-19 because it is a better substrate than ATP for the viral RNA-dependent RNA polymerase. iScience 23, 101849 (2020).","journal-title":"iScience"},{"key":"9844_CR7","doi-asserted-by":"publisher","unstructured":"Seifert, M. et al. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective. Elife 10, https:\/\/doi.org\/10.7554\/eLife.70968 (2021).","DOI":"10.7554\/eLife.70968"},{"key":"9844_CR8","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.jbc.2021.101529","volume":"298","author":"CJ Gordon","year":"2022","unstructured":"Gordon, C. J. et al. Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir. J. Biol. Chem. 298, 101529 (2022).","journal-title":"J. Biol. Chem."},{"key":"9844_CR9","doi-asserted-by":"publisher","unstructured":"Tchesnokov, E. P., Feng, J. Y., Porter, D. P. & Gotte, M. Mechanism of inhibition of Ebola Virus RNA-dependent RNA polymerase by remdesivir. Viruses 11, https:\/\/doi.org\/10.3390\/v11040326 (2019).","DOI":"10.3390\/v11040326"},{"key":"9844_CR10","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.jbc.2021.100770","volume":"297","author":"CJ Gordon","year":"2021","unstructured":"Gordon, C. J., Tchesnokov, E. P., Schinazi, R. F. & Gotte, M. Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template. J. Biol. Chem. 297, 100770 (2021).","journal-title":"J. Biol. Chem."},{"key":"9844_CR11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","volume":"28","author":"F Kabinger","year":"2021","unstructured":"Kabinger, F. et al. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat. Struct. Mol. Biol. 28, 740\u2013746 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"9844_CR12","doi-asserted-by":"publisher","first-page":"e1003565","DOI":"10.1371\/journal.ppat.1003565","volume":"9","author":"EC Smith","year":"2013","unstructured":"Smith, E. C., Blanc, H., Surdel, M. C., Vignuzzi, M. & Denison, M. R. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog. 9, e1003565 (2013).","journal-title":"PLoS Pathog."},{"key":"9844_CR13","doi-asserted-by":"publisher","first-page":"e1003760","DOI":"10.1371\/journal.ppat.1003760","volume":"9","author":"EC Smith","year":"2013","unstructured":"Smith, E. C. & Denison, M. R. Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity. PLoS Pathog. 9, e1003760 (2013).","journal-title":"PLoS Pathog."},{"key":"9844_CR14","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.0508200103","volume":"103","author":"E Minskaia","year":"2006","unstructured":"Minskaia, E. et al. Discovery of an RNA virus 3\u2019->5\u2019 exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc. Natl. Acad. Sci. USA 103, 5108\u20135113 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9844_CR15","doi-asserted-by":"publisher","first-page":"9372","DOI":"10.1073\/pnas.1201130109","volume":"109","author":"M Bouvet","year":"2012","unstructured":"Bouvet, M. et al. RNA 3\u2019-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10\/nsp14 exoribonuclease complex. Proc. Natl. Acad. Sci. USA 109, 9372\u20139377 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9844_CR16","doi-asserted-by":"publisher","unstructured":"Agostini, M. L. et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio 9, https:\/\/doi.org\/10.1128\/mBio.00221-18 (2018).","DOI":"10.1128\/mBio.00221-18"},{"key":"9844_CR17","doi-asserted-by":"publisher","unstructured":"Agostini, M. L. et al. Small-Molecule antiviral beta-d-N(4)-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance. J. Virol. 93, https:\/\/doi.org\/10.1128\/JVI.01348-19 (2019).","DOI":"10.1128\/JVI.01348-19"},{"key":"9844_CR18","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1007\/s00018-014-1695-z","volume":"71","author":"AJ te Velthuis","year":"2014","unstructured":"te Velthuis, A. J. Common and unique features of viral RNA-dependent polymerases. Cell Mol. Life Sci. 71, 4403\u20134420 (2014).","journal-title":"Cell Mol. Life Sci."},{"key":"9844_CR19","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.abc1560","volume":"368","author":"W Yin","year":"2020","unstructured":"Yin, W. et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science 368, 1499\u20131504 (2020).","journal-title":"Science"},{"key":"9844_CR20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41586-022-05664-3","volume":"614","author":"BF Malone","year":"2023","unstructured":"Malone, B. F. et al. Structural basis for substrate selection by the SARS-CoV-2 replicase. Nature 614, 781\u2013787 (2023).","journal-title":"Nature"},{"key":"9844_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20542-0","volume":"12","author":"G Kokic","year":"2021","unstructured":"Kokic, G. et al. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat. Commun. 12, 279 (2021).","journal-title":"Nat. Commun."},{"key":"9844_CR22","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.molcel.2021.01.035","volume":"81","author":"JPK Bravo","year":"2021","unstructured":"Bravo, J. P. K., Dangerfield, T. L., Taylor, D. W. & Johnson, K. A. Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication. Mol. Cell 81, 1548\u20131552 e1544 (2021).","journal-title":"Mol. Cell"},{"key":"9844_CR23","doi-asserted-by":"publisher","unstructured":"Lu, G. et al. Development of a simple in vitro assay to identify and evaluate nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase. Antimicrob. Agents Chemother. 65, https:\/\/doi.org\/10.1128\/AAC.01508-20 (2020).","DOI":"10.1128\/AAC.01508-20"},{"key":"9844_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","volume":"182","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. Structural basis for RNA replication by the SARS-CoV-2 polymerase. Cell 182, 417\u2013428 e413 (2020).","journal-title":"Cell"},{"key":"9844_CR25","doi-asserted-by":"publisher","first-page":"16156","DOI":"10.1074\/jbc.AC120.015720","volume":"295","author":"EP Tchesnokov","year":"2020","unstructured":"Tchesnokov, E. P. et al. Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action. J. Biol. Chem. 295, 16156\u201316165 (2020).","journal-title":"J. Biol. Chem."},{"key":"9844_CR26","doi-asserted-by":"publisher","first-page":"109882","DOI":"10.1016\/j.celrep.2021.109882","volume":"37","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex. Cell Rep. 37, 109882 (2021).","journal-title":"Cell Rep."},{"key":"9844_CR27","doi-asserted-by":"publisher","first-page":"107514","DOI":"10.1016\/j.jbc.2024.107514","volume":"300","author":"CJ Gordon","year":"2024","unstructured":"Gordon, C. J. et al. Mechanism and spectrum of inhibition of a 4\u2019-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses. J. Biol. Chem. 300, 107514 (2024).","journal-title":"J. Biol. Chem."},{"key":"9844_CR28","doi-asserted-by":"publisher","first-page":"eabo0718","DOI":"10.1126\/scitranslmed.abo0718","volume":"14","author":"LJ Stevens","year":"2022","unstructured":"Stevens, L. J. et al. Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms. Sci. Transl. Med. 14, eabo0718 (2022).","journal-title":"Sci. Transl. Med."},{"key":"9844_CR29","doi-asserted-by":"publisher","first-page":"106034","DOI":"10.1016\/j.antiviral.2024.106034","volume":"232","author":"B Sama","year":"2024","unstructured":"Sama, B. et al. The effects of Remdesivir\u2019s functional groups on its antiviral potency and resistance against the SARS-CoV-2 polymerase. Antivir. Res 232, 106034 (2024).","journal-title":"Antivir. Res"},{"key":"9844_CR30","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1021\/ja212027q","volume":"134","author":"N Zhang","year":"2012","unstructured":"Zhang, N., Zhang, S. & Szostak, J. W. Activated ribonucleotides undergo a sugar pucker switch upon binding to a single-stranded RNA template. J. Am. Chem. Soc. 134, 3691\u20133694 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"9844_CR31","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1073\/pnas.0610494104","volume":"104","author":"CE Chang","year":"2007","unstructured":"Chang, C. E., Chen, W. & Gilson, M. K. Ligand configurational entropy and protein binding. Proc. Natl. Acad. Sci. USA 104, 1534\u20131539 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9844_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1021\/bi00216a031","volume":"30","author":"MJ Donlin","year":"1991","unstructured":"Donlin, M. J., Patel, S. S. & Johnson, K. A. Kinetic partitioning between the exonuclease and polymerase sites in DNA error correction. Biochemistry 30, 538\u2013546 (1991).","journal-title":"Biochemistry"},{"key":"9844_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.virusres.2017.01.023","volume":"234","author":"CC Posthuma","year":"2017","unstructured":"Posthuma, C. C., Te Velthuis, A. J. W. & Snijder, E. J. Nidovirus RNA polymerases: complex enzymes handling exceptional RNA genomes. Virus Res. 234, 58\u201373 (2017).","journal-title":"Virus Res."},{"key":"9844_CR34","doi-asserted-by":"publisher","first-page":"22505","DOI":"10.1073\/pnas.1007626107","volume":"107","author":"P Gong","year":"2010","unstructured":"Gong, P. & Peersen, O. B. Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. USA 107, 22505\u201322510 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9844_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18463-z","volume":"11","author":"A Shannon","year":"2020","unstructured":"Shannon, A. et al. Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. Nat. Commun. 11, 4682 (2020).","journal-title":"Nat. Commun."},{"key":"9844_CR36","doi-asserted-by":"publisher","first-page":"e0067122","DOI":"10.1128\/jvi.00671-22","volume":"96","author":"G Campagnola","year":"2022","unstructured":"Campagnola, G., Govindarajan, V., Pelletier, A., Canard, B. & Peersen, O. B. The SARS-CoV nsp12 polymerase active site is tuned for large-genome replication. J. Virol. 96, e0067122 (2022).","journal-title":"J. Virol."},{"key":"9844_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00928361","volume":"140","author":"TW Traut","year":"1994","unstructured":"Traut, T. W. Physiological concentrations of purines and pyrimidines. Mol. Cell Biochem 140, 1\u201322 (1994).","journal-title":"Mol. Cell Biochem"},{"key":"9844_CR38","doi-asserted-by":"publisher","unstructured":"Palermiti, A. et al. A Novel HPLC-MS\/MS Method for the Intracellular Quantification of the Active Triphosphate Metabolite of Remdesivir: GS-443902. J. Xenobiot. 15, https:\/\/doi.org\/10.3390\/jox15040107 (2025).","DOI":"10.3390\/jox15040107"},{"key":"9844_CR39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/cts.12840","volume":"13","author":"R Humeniuk","year":"2020","unstructured":"Humeniuk, R. et al. Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID-19, in healthy subjects. Clin. Transl. Sci. 13, 896\u2013906 (2020).","journal-title":"Clin. Transl. Sci."},{"key":"9844_CR40","doi-asserted-by":"publisher","first-page":"e2519755122","DOI":"10.1073\/pnas.2519755122","volume":"122","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. Molecular basis of SARS-CoV-2 proofreading enzyme-mediated resistance to remdesivir. Proc. Natl. Acad. Sci. USA 122, e2519755122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9844_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29104-y","volume":"13","author":"S Gandhi","year":"2022","unstructured":"Gandhi, S. et al. De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report. Nat. Commun. 13, 1547 (2022).","journal-title":"Nat. Commun."},{"key":"9844_CR42","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/infdis\/jiad270","volume":"228","author":"C Hedskog","year":"2023","unstructured":"Hedskog, C. et al. Viral resistance analyses from the remdesivir phase 3 adaptive COVID-19 treatment trial-1 (ACTT-1). J. Infect. Dis. 228, 1263\u20131273 (2023).","journal-title":"J. Infect. Dis."},{"key":"9844_CR43","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/cid\/ciac769","volume":"76","author":"JI Hogan","year":"2023","unstructured":"Hogan, J. I. et al. Remdesivir resistance in transplant recipients with persistent coronavirus disease 2019. Clin. Infect. Dis. 76, 342\u2013345 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"9844_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47941-x","volume":"15","author":"H Igari","year":"2024","unstructured":"Igari, H. et al. Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19. Nat. Commun. 15, 3604 (2024).","journal-title":"Nat. Commun."},{"key":"9844_CR45","doi-asserted-by":"publisher","first-page":"e1762","DOI":"10.1093\/cid\/ciaa1474","volume":"73","author":"M Martinot","year":"2021","unstructured":"Martinot, M. et al. Emerging RNA-dependent RNA polymerase mutation in a remdesivir-treated B-cell immunodeficient patient with protracted coronavirus disease 2019. Clin. Infect. Dis. 73, e1762\u2013e1765 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"9844_CR46","doi-asserted-by":"publisher","first-page":"106264","DOI":"10.1016\/j.antiviral.2025.106264","volume":"242","author":"T Ichikawa","year":"2025","unstructured":"Ichikawa, T. et al. Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases. Antivir. Res. 242, 106264 (2025).","journal-title":"Antivir. Res."},{"key":"9844_CR47","doi-asserted-by":"publisher","unstructured":"Fernandez-Antunez, C. et al. SARS-CoV-2 remdesivir exposure leads to different evolutionary pathways that converge in moderate levels of drug resistance. Viruses 17, https:\/\/doi.org\/10.3390\/v17081055 (2025).","DOI":"10.3390\/v17081055"},{"key":"9844_CR48","doi-asserted-by":"publisher","unstructured":"Malone, B. et al. Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex. Proc. Natl. Acad. Sci. USA 118, https:\/\/doi.org\/10.1073\/pnas.2102516118 (2021).","DOI":"10.1073\/pnas.2102516118"},{"key":"9844_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.coviro.2013.03.014","volume":"3","author":"K Das","year":"2013","unstructured":"Das, K. & Arnold, E. HIV-1 reverse transcriptase and antiviral drug resistance. Part 2. Curr. Opin. Virol. 3, 119\u2013128 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"9844_CR50","doi-asserted-by":"publisher","first-page":"10027","DOI":"10.1073\/pnas.96.18.10027","volume":"96","author":"SG Sarafianos","year":"1999","unstructured":"Sarafianos, S. G. et al. Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids. Proc. Natl. Acad. Sci. USA 96, 10027\u201310032 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9844_CR51","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1128\/JVI.75.10.4771-4779.2001","volume":"75","author":"K Das","year":"2001","unstructured":"Das, K. et al. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J. Virol. 75, 4771\u20134779 (2001).","journal-title":"J. Virol."},{"key":"9844_CR52","doi-asserted-by":"publisher","first-page":"e1006889","DOI":"10.1371\/journal.ppat.1006889","volume":"14","author":"PC Jordan","year":"2018","unstructured":"Jordan, P. C. et al. Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase. PLoS Pathog. 14, e1006889 (2018).","journal-title":"PLoS Pathog."},{"key":"9844_CR53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren, T. K. et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531, 381\u2013385 (2016).","journal-title":"Nature"},{"key":"9844_CR54","doi-asserted-by":"publisher","first-page":"e0250610","DOI":"10.1371\/journal.pone.0250610","volume":"16","author":"C Madru","year":"2021","unstructured":"Madru, C. et al. Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli. PLoS One 16, e0250610 (2021).","journal-title":"PLoS One"},{"key":"9844_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"9844_CR56","doi-asserted-by":"publisher","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, https:\/\/doi.org\/10.7554\/eLife.42166 (2018).","DOI":"10.7554\/eLife.42166"},{"key":"9844_CR57","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"9844_CR58","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr"},{"key":"9844_CR59","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"9844_CR60","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"9844_CR61","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09844-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:04:21Z","timestamp":1777421061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09844-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9844"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09844-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7793649\/v1","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"591"}}